DANOS OLIVIER (Chief Scientific Officer) received a stock award from REGENXBIO INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2025ACC: 0001562180-25-000189
Officer· Chief Scientific Officer
Since Oct 2018
+142.44K
Net shares
Net buyer
$97.6K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
155.07K acquired · 12.63K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−12.63K
Price / share
$7.73
Trade value
$97.63K
% of position
6.8%
1/2/2025
185.08K→172.45K
Common Stock
Direct
Shares
+59.35K
Price / share
—
Trade value
—
% of position
34.4%
1/2/2025
172.45K→231.80K
Total
Net shares
+46.72K
Net value
-$97.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2025 | F · Tax Withholding | −12.63K | $7.73 | $97.63K | 6.8% | 185.08K | 172.45K |
| Common Stock Direct | 1/2/2025 | A · Award | +59.35K | — | — | 34.4% | 172.45K | 231.80K |
| Total | +46.72K | -$97.63K | ||||||
Derivative Transactions1
Stock Options (Right to buy)
Direct
Converts to
Common Stock
95.72K shares
Shares
+95.72K
Strike price
7.86
Held after
95.72K
Exercisable
—
1/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy) Direct | Common Stock95.72K shares | 1/2/2025 | A · Award | +95.72K | 7.86 | — | 95.72K |